The global C1 Esterase Inhibitor Subcutaneous market was valued at 652 million in 2024 and is projected to reach US$ 1206 million by 2031, at a CAGR of 9.4% during the forecast period.
C1 esterase inhibitor is used to treat or prevent hereditary angioedema (HAE).
The C1 esterase inhibitor subcutaneous market is driven by a growing awareness and diagnosis of hereditary angioedema (HAE) and other related disorders. As more patients are identified and diagnosed with these conditions, there is an increasing demand for effective treatment options like subcutaneous C1 esterase inhibitors. Additionally, advancements in biotechnology and medical research have led to the development of novel therapies, further fueling market growth. However, the market also faces challenges, such as high treatment costs and limited accessibility to these specialized therapies. Additionally, stringent regulatory requirements and the need for robust clinical evidence for new products present hurdles for companies operating in this sector. Overcoming these challenges while addressing the unmet medical needs of patients will be crucial for sustained growth in the C1 esterase inhibitor subcutaneous market.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the C1 Esterase Inhibitor Subcutaneous manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for C1 Esterase Inhibitor Subcutaneous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C1 Esterase Inhibitor Subcutaneous. This report contains market size and forecasts of C1 Esterase Inhibitor Subcutaneous in global, including the following market information:
Global C1 Esterase Inhibitor Subcutaneous market revenue, 2020-2025, 2026-2031, ($ millions)
Global C1 Esterase Inhibitor Subcutaneous market sales, 2020-2025, 2026-2031, (Units)
Global top five C1 Esterase Inhibitor Subcutaneous companies in 2024 (%)
Total Market by Segment:
Global C1 Esterase Inhibitor Subcutaneous market, by Type, 2020-2025, 2026-2031 ($ millions) & (Units)
Global C1 Esterase Inhibitor Subcutaneous market segment percentages, by Type, 2024 (%)
500U
1000U
Global C1 Esterase Inhibitor Subcutaneous market, by Application, 2020-2025, 2026-2031 ($ Millions) & (Units)
Global C1 Esterase Inhibitor Subcutaneous market segment percentages, by Application, 2024 (%)
Children
Adult
Global C1 Esterase Inhibitor Subcutaneous market, by region and country, 2020-2025, 2026-2031 ($ millions) & (Units)
Global C1 Esterase Inhibitor Subcutaneous market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies C1 Esterase Inhibitor Subcutaneous revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies C1 Esterase Inhibitor Subcutaneous revenues share in global market, 2024 (%)
Key companies C1 Esterase Inhibitor Subcutaneous sales in global market, 2020-2025 (estimated), (Units)
Key companies C1 Esterase Inhibitor Subcutaneous sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
CSL Behring
Outline of Major Chapters:
Chapter 1: Introduces the definition of C1 Esterase Inhibitor Subcutaneous, market overview.
Chapter 2: Global C1 Esterase Inhibitor Subcutaneous market size in revenue and volume.
Chapter 3: Detailed analysis of C1 Esterase Inhibitor Subcutaneous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of C1 Esterase Inhibitor Subcutaneous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global C1 Esterase Inhibitor Subcutaneous capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 C1 Esterase Inhibitor Subcutaneous Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global C1 Esterase Inhibitor Subcutaneous Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global C1 Esterase Inhibitor Subcutaneous Overall Market Size
2.1 Global C1 Esterase Inhibitor Subcutaneous Market Size: 2024 VS 2031
2.2 Global C1 Esterase Inhibitor Subcutaneous Market Size, Prospects & Forecasts: 2020-2031
2.3 Global C1 Esterase Inhibitor Subcutaneous Sales: 2020-2031
3 Company Landscape
3.1 Top C1 Esterase Inhibitor Subcutaneous Players in Global Market
3.2 Top Global C1 Esterase Inhibitor Subcutaneous Companies Ranked by Revenue
3.3 Global C1 Esterase Inhibitor Subcutaneous Revenue by Companies
3.4 Global C1 Esterase Inhibitor Subcutaneous Sales by Companies
3.5 Global C1 Esterase Inhibitor Subcutaneous Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 C1 Esterase Inhibitor Subcutaneous Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers C1 Esterase Inhibitor Subcutaneous Product Type
3.8 Tier 1, Tier 2, and Tier 3 C1 Esterase Inhibitor Subcutaneous Players in Global Market
3.8.1 List of Global Tier 1 C1 Esterase Inhibitor Subcutaneous Companies
3.8.2 List of Global Tier 2 and Tier 3 C1 Esterase Inhibitor Subcutaneous Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Market Size Markets, 2024 & 2031
4.1.2 500U
4.1.3 1000U
4.2 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Revenue & Forecasts
4.2.1 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Revenue, 2020-2025
4.2.2 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Revenue, 2026-2031
4.2.3 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
4.3 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Sales & Forecasts
4.3.1 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Sales, 2020-2025
4.3.2 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Sales, 2026-2031
4.3.3 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
4.4 Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Market Size, 2024 & 2031
5.1.2 Children
5.1.3 Adult
5.2 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Revenue & Forecasts
5.2.1 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Revenue, 2020-2025
5.2.2 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Revenue, 2026-2031
5.2.3 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
5.3 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Sales & Forecasts
5.3.1 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Sales, 2020-2025
5.3.2 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Sales, 2026-2031
5.3.3 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
5.4 Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global C1 Esterase Inhibitor Subcutaneous Market Size, 2024 & 2031
6.2 By Region - Global C1 Esterase Inhibitor Subcutaneous Revenue & Forecasts
6.2.1 By Region - Global C1 Esterase Inhibitor Subcutaneous Revenue, 2020-2025
6.2.2 By Region - Global C1 Esterase Inhibitor Subcutaneous Revenue, 2026-2031
6.2.3 By Region - Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
6.3 By Region - Global C1 Esterase Inhibitor Subcutaneous Sales & Forecasts
6.3.1 By Region - Global C1 Esterase Inhibitor Subcutaneous Sales, 2020-2025
6.3.2 By Region - Global C1 Esterase Inhibitor Subcutaneous Sales, 2026-2031
6.3.3 By Region - Global C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America C1 Esterase Inhibitor Subcutaneous Revenue, 2020-2031
6.4.2 By Country - North America C1 Esterase Inhibitor Subcutaneous Sales, 2020-2031
6.4.3 United States C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.4.4 Canada C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.4.5 Mexico C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe C1 Esterase Inhibitor Subcutaneous Revenue, 2020-2031
6.5.2 By Country - Europe C1 Esterase Inhibitor Subcutaneous Sales, 2020-2031
6.5.3 Germany C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.5.4 France C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.5.5 U.K. C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.5.6 Italy C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.5.7 Russia C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.5.8 Nordic Countries C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.5.9 Benelux C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia C1 Esterase Inhibitor Subcutaneous Revenue, 2020-2031
6.6.2 By Region - Asia C1 Esterase Inhibitor Subcutaneous Sales, 2020-2031
6.6.3 China C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.6.4 Japan C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.6.5 South Korea C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.6.6 Southeast Asia C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.6.7 India C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America C1 Esterase Inhibitor Subcutaneous Revenue, 2020-2031
6.7.2 By Country - South America C1 Esterase Inhibitor Subcutaneous Sales, 2020-2031
6.7.3 Brazil C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.7.4 Argentina C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa C1 Esterase Inhibitor Subcutaneous Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa C1 Esterase Inhibitor Subcutaneous Sales, 2020-2031
6.8.3 Turkey C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.8.4 Israel C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.8.5 Saudi Arabia C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
6.8.6 UAE C1 Esterase Inhibitor Subcutaneous Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda C1 Esterase Inhibitor Subcutaneous Major Product Offerings
7.1.4 Takeda C1 Esterase Inhibitor Subcutaneous Sales and Revenue in Global (2020-2025)
7.1.5 Takeda Key News & Latest Developments
7.2 CSL Behring
7.2.1 CSL Behring Company Summary
7.2.2 CSL Behring Business Overview
7.2.3 CSL Behring C1 Esterase Inhibitor Subcutaneous Major Product Offerings
7.2.4 CSL Behring C1 Esterase Inhibitor Subcutaneous Sales and Revenue in Global (2020-2025)
7.2.5 CSL Behring Key News & Latest Developments
8 Global C1 Esterase Inhibitor Subcutaneous Production Capacity, Analysis
8.1 Global C1 Esterase Inhibitor Subcutaneous Production Capacity, 2020-2031
8.2 C1 Esterase Inhibitor Subcutaneous Production Capacity of Key Manufacturers in Global Market
8.3 Global C1 Esterase Inhibitor Subcutaneous Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 C1 Esterase Inhibitor Subcutaneous Supply Chain Analysis
10.1 C1 Esterase Inhibitor Subcutaneous Industry Value Chain
10.2 C1 Esterase Inhibitor Subcutaneous Upstream Market
10.3 C1 Esterase Inhibitor Subcutaneous Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 C1 Esterase Inhibitor Subcutaneous Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of C1 Esterase Inhibitor Subcutaneous in Global Market
Table 2. Top C1 Esterase Inhibitor Subcutaneous Players in Global Market, Ranking by Revenue (2024)
Table 3. Global C1 Esterase Inhibitor Subcutaneous Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global C1 Esterase Inhibitor Subcutaneous Revenue Share by Companies, 2020-2025
Table 5. Global C1 Esterase Inhibitor Subcutaneous Sales by Companies, (Units), 2020-2025
Table 6. Global C1 Esterase Inhibitor Subcutaneous Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers C1 Esterase Inhibitor Subcutaneous Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers C1 Esterase Inhibitor Subcutaneous Product Type
Table 9. List of Global Tier 1 C1 Esterase Inhibitor Subcutaneous Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 C1 Esterase Inhibitor Subcutaneous Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Sales (Units), 2020-2025
Table 15. Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Sales (Units), 2026-2031
Table 16. Segment by Application – Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2020-2025
Table 20. Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2026-2031
Table 21. By Region – Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2020-2025
Table 25. By Region - Global C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2026-2031
Table 26. By Country - North America C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2020-2025
Table 29. By Country - North America C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2026-2031
Table 30. By Country - Europe C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2020-2025
Table 33. By Country - Europe C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2026-2031
Table 34. By Region - Asia C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2020-2025
Table 37. By Region - Asia C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2026-2031
Table 38. By Country - South America C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2020-2025
Table 41. By Country - South America C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2026-2031
Table 42. By Country - Middle East & Africa C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2020-2025
Table 45. By Country - Middle East & Africa C1 Esterase Inhibitor Subcutaneous Sales, (Units), 2026-2031
Table 46. Takeda Company Summary
Table 47. Takeda C1 Esterase Inhibitor Subcutaneous Product Offerings
Table 48. Takeda C1 Esterase Inhibitor Subcutaneous Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Takeda Key News & Latest Developments
Table 50. CSL Behring Company Summary
Table 51. CSL Behring C1 Esterase Inhibitor Subcutaneous Product Offerings
Table 52. CSL Behring C1 Esterase Inhibitor Subcutaneous Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. CSL Behring Key News & Latest Developments
Table 54. C1 Esterase Inhibitor Subcutaneous Capacity of Key Manufacturers in Global Market, 2023-2025 (Units)
Table 55. Global C1 Esterase Inhibitor Subcutaneous Capacity Market Share of Key Manufacturers, 2023-2025
Table 56. Global C1 Esterase Inhibitor Subcutaneous Production by Region, 2020-2025 (Units)
Table 57. Global C1 Esterase Inhibitor Subcutaneous Production by Region, 2026-2031 (Units)
Table 58. C1 Esterase Inhibitor Subcutaneous Market Opportunities & Trends in Global Market
Table 59. C1 Esterase Inhibitor Subcutaneous Market Drivers in Global Market
Table 60. C1 Esterase Inhibitor Subcutaneous Market Restraints in Global Market
Table 61. C1 Esterase Inhibitor Subcutaneous Raw Materials
Table 62. C1 Esterase Inhibitor Subcutaneous Raw Materials Suppliers in Global Market
Table 63. Typical C1 Esterase Inhibitor Subcutaneous Downstream
Table 64. C1 Esterase Inhibitor Subcutaneous Downstream Clients in Global Market
Table 65. C1 Esterase Inhibitor Subcutaneous Distributors and Sales Agents in Global Market
List of Figures
Figure 1. C1 Esterase Inhibitor Subcutaneous Product Picture
Figure 2. C1 Esterase Inhibitor Subcutaneous Segment by Type in 2024
Figure 3. C1 Esterase Inhibitor Subcutaneous Segment by Application in 2024
Figure 4. Global C1 Esterase Inhibitor Subcutaneous Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global C1 Esterase Inhibitor Subcutaneous Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global C1 Esterase Inhibitor Subcutaneous Revenue: 2020-2031 (US$, Mn)
Figure 8. C1 Esterase Inhibitor Subcutaneous Sales in Global Market: 2020-2031 (Units)
Figure 9. The Top 3 and 5 Players Market Share by C1 Esterase Inhibitor Subcutaneous Revenue in 2024
Figure 10. Segment by Type – Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit), 2020-2031
Figure 18. By Region – Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
Figure 21. By Region - Global C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
Figure 22. By Country - North America C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
Figure 23. By Country - North America C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
Figure 24. United States C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 25. Canada C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
Figure 28. By Country - Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
Figure 29. Germany C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 30. France C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 32. Italy C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 33. Russia C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
Figure 37. By Region - Asia C1 Esterase Inhibitor Subcutaneous Sales Market Share, 2020-2031
Figure 38. China C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 39. Japan C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 42. India C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America C1 Esterase Inhibitor Subcutaneous Revenue Market Share, 2020-2031
Figure 44. By Country - South America C1 Esterase Inhibitor Subcutaneous Sales, Market Share, 2020-2031
Figure 45. Brazil C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa C1 Esterase Inhibitor Subcutaneous Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa C1 Esterase Inhibitor Subcutaneous Sales, Market Share, 2020-2031
Figure 49. Turkey C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 50. Israel C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 52. UAE C1 Esterase Inhibitor Subcutaneous Revenue, (US$, Mn), 2020-2031
Figure 53. Global C1 Esterase Inhibitor Subcutaneous Production Capacity (Units), 2020-2031
Figure 54. The Percentage of Production C1 Esterase Inhibitor Subcutaneous by Region, 2024 VS 2031
Figure 55. C1 Esterase Inhibitor Subcutaneous Industry Value Chain
Figure 56. Marketing Channels
